PEDIATRICS Vol. 99 No. 5 May 1997,
p. e1
Copyright ©1997 by the American Academy of Pediatrics
ELECTRONIC ARTICLE:
Magnesium Sulfate in Labor and Risk of Neonatal Brain Lesions and
Cerebral Palsy in Low Birth Weight Infants
Received Apr 10, 1996; accepted Nov 4, 1996.
,
, and
From the * Program in Epidemiology and Department of
Pediatrics and Human Development, College of Human Medicine, Michigan
State University, East Lansing, Michigan; § College of Nursing,
University of Pennsylvania, Philadelphia, Pennsylvania; and
Sergievsky Center and School of Public Health, Columbia University,
New York, New York.
Objectives. We tested the hypothesis that administration of magnesium sulfate in labor protects against the development of neonatal brain lesions and cerebral palsy (CP) in low birth weight infants.
Methods. Magnesium exposure was ascertained in a population-based cohort of 1105 infants weighing 2000 g or less through review of medical records of maternal magnesium sulfate administration and, where available, elevated maternal serum magnesium levels. Neonatal germinal matrix/intraventricular hemorrhage and parenchymal brain lesions were ascertained by a prospective, timed ultrasound scanning protocol in the first week of life. CP was ascertained at 2 years of age by clinical examination in 80% of survivors and by interview and medical record review in another 6% and was classified as disabling or nondisabling.
Results. No significant reduction in risk of nondisabling CP (adjusted odds ratio [OR], 1.00; 95% confidence interval [CI], 0.53 to 1.88) or disabling CP [DCP] (adjusted OR, 0.63; 95% CI, 0.32 to 1.24) CP with magnesium exposure was found in a logistic regression model that controlled for gestational age, fetal growth, gender, multiple birth status, mode of delivery, amnionitis, and hypertensive disorders. In a small subset of infants, those with onset of parenchymal lesions at 7 days of age or later (n = 29), magnesium exposure was associated with a significantly reduced risk of DCP (OR, 0.10; 95% CI, 0.02 to 0.65). Magnesium sulfate exposure was not associated with germinal matrix/intraventricular hemorrhage (adjusted OR, 0.89; 95% CI, 0.64 to 1.25) or with parenchymal brain lesions (adjusted OR, 0.83; 95% CI, 0.53 to 1.30).
Conclusions. The hypothesis that magnesium sulfate use reduces the risk of neonatal brain lesions or CP in low birth weight infants was not statistically supported in this study, although a modest reduction in risk of DCP cannot be excluded. The data further suggest that magnesium exposure may be associated with reduction in risk of CP in low birth weight infants who have late-onset brain lesions, but this unpredicted observation requires confirmation in another data set. cerebral palsy; magnesium sulfate; infant, low birth weight; preeclampsia; cerebral hemorrhage, infant.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J Kuepper-Nybelen, A Lamerz, N Bruning, J Hebebrand, B Herpertz-Dahlmann, and H Brenner Major differences in prevalence of overweight according to nationality in preschool children living in Germany: determinants and public health implications Arch. Dis. Child., April 1, 2005; 90(4): 359 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Kuppermann Intracranial injury in minor head trauma Arch. Dis. Child., July 1, 2004; 89(7): 593 - 594. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Koivunen, M. Uhari, J. Luotonen, A. Kristo, R. Raski, T. Pokka, and O.-P. Alho Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial BMJ, February 28, 2004; 328(7438): 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Crowther, J. E. Hiller, L. W. Doyle, and R. R. Haslam Effect of Magnesium Sulfate Given for Neuroprotection Before Preterm Birth: A Randomized Controlled Trial JAMA, November 26, 2003; 290(20): 2669 - 2676. [Abstract] [Full Text] [PDF]
|
|
